Home
About
Services
Partners
Client Portfolio
News
Contact
Lilly lifts earnings forecast as newer drugs provide boost
November 6, 2018
Iran says it is selling the oil it needs to, despite U.S. pressure
November 6, 2018
0
Lilly to consider more acquisitions like $1.6 billion Armo buy
Published by
Muller&Green
at
November 6, 2018
Categories
RSS
Tags
Eli Lilly and Co will consider more acquisitions similar to its $1.6 billion purchase of cancer drug developer Armo Biosciences earlier this year, the drugmaker’s chief financial officer said on Tuesday.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more